CORO7

Across TCGA pan-cancer cohorts, CORO7 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CORO7 data layer compared with 24 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in thyroid carcinoma (THCA), where higher CORO7 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CORO7 expression acts as an unfavorable survival marker.

THCA, PCPG, and UCEC are the cancer types where CORO7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Median	All	0.136	0.842	.002	12	view →
PCPG	OS	Median	All	0.010	0.946	<.001	12	view →
UCEC	OS	Median	IV	0.225	0.772	<.001	12	view →
PRAD	DFS	Median	All	0.617	0.886	.038	6	view →
LIHC	DFS	Median	All	0.125	0.555	.010	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CORO7–THCA (DFS)

Open the THCA breakdown →